Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 4/20 | 0.53 |
| ▸ | CYP4A11 | Q02928 | 4/20 | 0.53 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.50 |
| ▸ | NOS1 | P29475 | 2/20 | 0.48 |
| ▸ | LTA4H | P09960 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | NOS3 | P29474 | 1/20 | 0.43 |
| ▸ | NOS2 | P35228 | 1/20 | 0.43 |
| ▸ | IGF1R | P08069 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | LPL | P06858 | 2/20 | 0.42 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | DRD2 | P14416 | 1/20 | 0.41 |
| ▸ | DRD1 | P21728 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1244841 | 0.93 | CYP4F2 (0.49) | CYP4F2CYP4A11TBXA2RNOS1LTA4H | |
| SCHEMBL238401 | 0.92 | CYP4F2 (0.58) | CYP4F2CYP4A11TBXA2RNOS1TDP1 | |
| SCHEMBL2176833 | 0.90 | CYP4F2 (0.56) | CYP4F2CYP4A11TBXA2RNOS1IGF1R | |
| SCHEMBL613331 | 0.89 | TAAR1 (0.48) | CYP4F2CYP4A11TBXA2RNOS1LTA4H | |
| SCHEMBL27451458 | 0.89 | ENPP2 (0.52) | CYP4F2CYP4A11TBXA2RNOS1CYP2D6 | |
| SCHEMBL8464457 | 0.89 | CYP4F2 (0.54) | CYP4F2CYP4A11TBXA2RLPLLIPG | |
| SCHEMBL80185 | 0.89 | CYP4A11 (0.58) | CYP4F2CYP4A11TBXA2RNOS1LTA4H | |
| SCHEMBL15250083 | 0.87 | TDP1 (0.56) | CYP4F2CYP4A11TBXA2RNOS1TDP1 | |
| SCHEMBL3118552 | 0.87 | MTNR1A (0.49) | CYP4F2CYP4A11TBXA2RNOS1LTA4H | |
| SCHEMBL29616870 | 0.86 | DRD2 (0.61) | ALOX15DRD2DRD1TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4512612-A2 | POLYETHERS CONTAINING NON-BISPHENOLIC CYCLIC GROUPS | Swimc LLC (US) | 2025-02-26 | — | — | EP | claimed |
| CN-113227353-A | Microbial cells and methods for cannabinoid production | 马努斯生物合成股份有限公司 | 2021-08-06 | — | — | CN | claimed |
| US-20200317953-A1 | POLYETHERS CONTAINING NON-BISPHENOLIC CYCLIC GROUPS | SWIMC LLC (US) | 2020-10-08 | — | — | US | claimed |
| US-10793742-B2 | Polyethers containing non-bisphenolic cyclic groups | VALSPAR SOURCING, INC. (US) | 2020-10-06 | — | — | US | claimed |
| EP-3146009-A1 | POLYETHERS CONTAINING NON-BISPHENOLIC CYCLIC GROUPS | Valspar Sourcing, Inc. (US) | 2017-03-29 | — | — | EP | claimed |
| US-20170051177-A1 | POLYETHERS CONTAINING NON-BISPHENOLIC CYCLIC GROUPS | SWIMC LLC | 2017-02-23 | — | — | US | claimed |
| WO-2015179064-A1 | POLYETHERS CONTAINING NON-BISPHENOLIC CYCLIC GROUPS | VALSPAR SOURCING, INC. (US) | 2015-11-26 | — | — | WO | claimed |
| EP-4512612-A2 | POLYETHERS CONTAINING NON-BISPHENOLIC CYCLIC GROUPS | Swimc LLC (US) | 2025-02-26 | — | — | EP | disclosed |
| US-20250025854-A1 | EMM-41 COMPOSITION, METHODS OF MAKING AND USES THEREOF | ExxonMobil Technology and Engineering Company | 2025-01-23 | — | — | US | disclosed |
| US-20250025855-A1 | EMM-41 COMPOSITION, METHODS OF MAKING AND USES THEREOF | ExxonMobil Technology and Engineering Company | 2025-01-23 | — | — | US | disclosed |
| US-12161990-B2 | EMM-41 composition, methods of making and uses thereof | ExxonMobil Technology and Engineering Company (US) | 2024-12-10 | — | — | US | disclosed |
| EP-3146009-B1 | POLYETHERS CONTAINING NON-BISPHENOLIC CYCLIC GROUPS | SWIMC LLC (US) | 2024-10-02 | — | — | EP | disclosed |
| CN-113165893-B | EMM-41 compositions, methods of manufacture and uses thereof | 埃克森美孚科技工程公司 | 2024-06-11 | — | — | CN | disclosed |
| EP-2308914-A1 | POLYCARBONATE DIOL AND POLYCARBONATE DIOL COPOLYMER | Ube Industries, Ltd. (JP) | 2011-04-13 | — | — | EP | disclosed |
| US-20100069432-A1 | Bis-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2010-03-18 | — | — | US | disclosed |
| US-7557126-B2 | Diphenylmethyl compounds useful as muscarinic receptor antagonists | THERAVANCE, INC. (US) | 2009-07-07 | — | — | US | disclosed |
| US-20070254943-A1 | Diphenylmethyl compounds useful as muscarinic receptor antagonists | THERAVANCE BIOPHARMA R&D IP, LLC | 2007-11-01 | — | — | US | disclosed |
| US-7250414-B2 | Diphenylmethyl compounds useful as muscarinic receptor antagonists | THERAVANCE, INC. (US) | 2007-07-31 | — | — | US | disclosed |
| US-20050203167-A1 | Diphenylmethyl compounds useful as muscarinic receptor antagonists | THERAVANCE, INC. | 2005-09-15 | — | — | US | disclosed |
| US-4129413-A | Oxidation hair dyes based upon tetraaminopyrimidine developers and mono- and dialkyl -m- dihydroxy benzene couplers | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 1978-12-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250025855-A1 | EMM-41 COMPOSITION, METHODS OF MAKING AND USES THEREOF | CD14, CD68, MASP2 | CYP4F2 3757/4885CYP4A11 3308/4885TBXA2R 3591/4885 |
| US-12161990-B2 | EMM-41 composition, methods of making and uses thereof | CD14, CD68, MASP2 | CYP4F2 3757/4885CYP4A11 3308/4885TBXA2R 3591/4885 |
| US-20050203167-A1 | Diphenylmethyl compounds useful as muscarinic receptor antagonists | CHRM1, CHRM2, CHRM3 | CYP4F2 1689/4885CYP4A11 935/4885TBXA2R 48/4885 |
| US-20070254943-A1 | Diphenylmethyl compounds useful as muscarinic receptor antagonists | CHRM1, CHRM2, CHRM3 | CYP4F2 1689/4885CYP4A11 935/4885TBXA2R 48/4885 |
| US-20100069432-A1 | Bis-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors | CHRNA2, CHRNA5, CHRNA4 | CYP4F2 2588/4885CYP4A11 2417/4885TBXA2R 1301/4885 |
| US-20250025854-A1 | EMM-41 COMPOSITION, METHODS OF MAKING AND USES THEREOF | CD14, CD68, MASP2 | CYP4F2 3757/4885CYP4A11 3308/4885TBXA2R 3591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.